Jaydip Ghadage's Blog

Biopsy Guidance System Market is projected to reach a valuation of US$ 2 Billion by 2032

Jaydip Ghadage's photo
Jaydip Ghadage
·

3 min read

According to Future Market Insights’ newly released Biopsy Guidance System Market analysis report, global sales of the Biopsy Guidance System Market in 2021 were held at US$ 1.1 Billion. The market is expected to reach a valuation of US$ 2 billion by 2032, with a CAGR of 5.8% between 2022 and 2032. Stereotactic Guided Biopsy is expected to be the highest revenue-generating segment, growing at a CAGR of 6.1% between 2022 and 2032.

Get Full Access @ https://www.futuremarketinsights.com/reports/biopsy-guidance-system-market

According to Future Market Insights, a supplier of market research and competitive data, the market value of the Biopsy Guidance System Market increased historically between 2017 and 2021 at a CAGR of roughly 5.1%.

The primary factors driving the market include the rising incidence of cancer, the ageing population, the increased desire for minimally invasive procedures, technical advancements, and government efforts. Breast, brain, skin, and prostate cancers are among the chronic conditions for which a biopsy is one of the most often utilised diagnostic techniques.

Biopsy Navigation System is a medical device that assists physicians in obtaining tissue samples from a patient’s body for diagnostic purposes. The system includes imaging technology such as ultrasound, MRI, or CT scans to locate the tissue that needs to be sampled, and a needle or other device that is used to extract the tissue.

FMI, in its business report, elaborates the historical and current scenario of the global Biopsy Guidance System market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7

  • Prompt and efficient customer service

  • Data collected from reliable primary and secondary sources

  • Highly trained and experienced team of research analysts

  • Seamless delivery of tailor-made market research reports

Key Companies Profiled:

  • Becton, Dickinson, and Company

  • Hologic, Inc.

  • Devicor Medical Products, Inc.

  • B. Braun Melsungen AG

  • ARGON MEDICAL

  • Boston Scientific Corporation

  • INRAD Inc.

  • Cook Medical

  • PLANMED OY

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets

  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.

  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis

  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions

  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Biopsy Guidance System market

Market Segments Covered in Biopsy Guidance System Market Analysis

By Product Type:

  • Stereotactic Guided Biopsy

  • Ultrasound Guided Biopsy

  • MRI Guided Biopsy

By Application:

  • Brain Biopsy

  • Breast Biopsy

  • Other Applications

By End-User:

  • Hospitals

  • Specialty Clinics

  • Diagnostic Centres

  • Research and Academic Institutes

Biopsy Guidance System Market